TP53 and neoplasm: Frequent genetic mutations in breast cancer, such as TP53, PIK3CA, and GATA3, play a key role in shaping tumor aggressiveness and influencing treatment outcomes (Martínez-Sáez et al., 2020; Mosele et al., 2020).